Literature DB >> 15319708

Cyclosporine A-induced ocular opsoclonus and reversible leukoencephalopathy after orthotopic liver transplantation: brief report.

Paulo Eurípedes Marchiori1, Sergio Mies, Milberto Scaff.   

Abstract

Ocular opsoclonus is a rare neurologic condition that occurs in patients with brain stem encephalitis, neoplasm of the mesencephalon, paraneoplastic syndrome or intoxication. Neurotoxicity is a well-known complication of cyclosporine-A (CSA) therapy. We report a case of a 17-year-old patient, a Caucasian female, who underwent an orthotopic liver transplantation (OLT) for immunologic cirrhosis and chronic cellular rejection respectively. The ocular symptoms occurred 8 days after the OLT. She also developed reversible posterior leukoencephalopathy. The serum level of CSA was 412 ng/mL. The ocular symptoms improved 21 days after the reduction of the CSA level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319708     DOI: 10.1097/01.wnf.0000134409.97397.5e

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  3 in total

1.  Deoxyspergualin, an immunosuppressant, in patients suffering from nephropathies with crescent formation: an open-label trial to evaluate safety and efficacy.

Authors:  Hirokazu Imai; Osamu Hotta; Mitsuhiro Yoshimura; Tsuneo Konta; Yoshiharu Tsubakihara; Masanobu Miyazaki; Chie Tomida; Masaki Kobayashi; Satoshi Suzuki; Hideo Shiiki; Atsushi Yamauchi; Hitoshi Yokoyama; Masato Nose
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

Review 2.  Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.

Authors:  Turun Song; Zhengsheng Rao; Qiling Tan; Yang Qiu; Jinpeng Liu; Zhongli Huang; Xianding Wang; Tao Lin
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Posterior Reversible Encephalopathy Syndrome Presenting as Opsoclonus-Myoclonus.

Authors:  Torrey Boland; Jamie Strause; Myra Hu; Dolores Santamaria; Tsao-Wei Liang; Daniel Kremens; Robert Sergott; Michael Moussouttas
Journal:  Neuroophthalmology       Date:  2012-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.